HemoPoint H2 Hemoglobin DMS of Stanbio approved
Stanbio Laboratory announced that the FDA has approved its HemoPoint H2 Hemoglobin Data Management System (DMS), which provides both a hemoglobin and calculated hematocrit result with one simple test. The new, HemoPoint H2 DMS utilizes connectivity to PCs via Bluetooth, control intervals and barcode identification of operators and patients to offer time-saving convenience, ease of data management technology and high quality control.

InfraScan has received the European marketing clearance (CE mark), for its handheld brain hematoma detector. This approval certifies that
The U.S. Food and Drug Administration has cleared the
Designer and manufacturer of NOVA™ (Non-invasive Optimal Vessel Analysis), VasSol, Inc. has announced that the technology will now be available in European markets. The company entered into a partnership with Tekmed Instruments, its Italian distributor, during the last month. NOVA™ is a non-invasive tool for the measurement of blood flow. The Quantitative MRA software does not need a contrast solution to be injected. Nor is there a requirement to expose the patient to radiation. The technology has useful vascular applications.
Researchers have come up with a new test that can determine whether the mother and baby are going to have different blood types or not. Published on